TITLE

Prevention and treatment of malignant hyperthermia in certified training hospitals in Japan: a questionnaire

AUTHOR(S)
Suyama, Hidemichi; Kawamoto, Masashi; Yuge, Osafumi
PUB. DATE
August 2002
SOURCE
Journal of Anesthesia;2002, Vol. 16 Issue 3, p207
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
.Purpose. To assess the preparedness of hospitals in Japan for cases of malignant hyperthermia (MH).Method. A survey was sent to 884 training hospitals certified by the Japan Society of Anesthesiologists (JSA) in June and July 2000. Useful answers were received from 431 (48.8%) institutions.Results. For general anesthesia, inhalation anesthetics were widely used in 283 (65.7%) hospitals, and succinylcholine was the most commonly used muscle relaxant, which was used in 270 hospitals (62.5%). For patient monitoring, 422 (97.9%) hospitals used a pulse oximeter for all general anesthesia cases. A capnogram was used in 152 (35.3%) hospitals, and continuous body temperature was measured in 128 (29.7%). Two hundred and eighty-eight (66.8%) hospitals had more than six vials of dantrolene prepared for use, whereas 13 (3.0%) had none.Conclusion. The results of the survery revealed that some hospitals had inadequate monitoring methods and a lack of prepared dantrolene for cases of MH under general anesthesia. We recommend that essential monitors be deployed and adequate preparations of dantrolene be maintained for effective early diagnosis and treatment of MH.
ACCESSION #
7075352

 

Related Articles

  • Malignant Hyperthermia Susceptibility and the Trauma Patient. Sheehan, Jacqueline A. // Military Medicine;Jun2005, Vol. 170 Issue 6, p510 

    Assorted casualties are expected from combat. Triage of the wounded may result in some going directly to surgery. Although every minute is essential, anesthetic care of these trauma patients must adhere to all established standards of care. A timely preoperative assessment must include...

  • Malignant Hyperthermia In The Indian Subcontinent: Non-availability Of Dantrolene - A Cause For Concern? Pu, Jyotsna; Bhatnagar, Sushma; saxena, Abha // Internet Journal of Pharmacology;2002, Vol. 1 Issue 1, p3 

    We report the first case of malignant hyperthermia from the Indian sub-continent and raise the issue of non-availability of dantrolene in a country, where this clinical entity was thought not to exist.

  • Neuroleptic Malignant Syndrome: Response to Dantrolene Sodium. May, David C.; Morris, Stephan W.; Stewart, R. Malcolm; Fenton, Barry J.; Gaffney, F. Andrew // Annals of Internal Medicine;Feb83, Vol. 98 Issue 2, p183 

    Presents a case study of a patient with haloperidol-induced neuroleptic malignant syndrome. Clinical presentation of the patient; Efficacy of oral dantrolene sodium in treating the patient; Similarity between neuroleptic malignant syndrome and malignant hyperthermia; Physiological...

  • Malignant hyperthermia. Morris, David // Independent Nurse;2/21/2011, p23 

    The article offers information on malignant hyperthermia (MH), a rare condition that occurs following the use of general anaesthetic (GA) agents. It outlines the clinical features of MH, including increasing muscle tone that leads to rigidity, tachycardia, hypertension, sweating and skin...

  • Malignant hyperthermia: pharmacology of triggering. Hopkins, P. M. // BJA: The British Journal of Anaesthesia;Jul2011, Vol. 107 Issue 1, p48 

    Over the past 50 yr, many drugs have been implicated as triggers of malignant hyperthermia (MH), a potentially fatal pharmacogenetic disorder of skeletal muscle calcium regulation. This review discusses the potent inhalation agents as the principal triggers and evidence that the modern agents,...

  • Malignant Hyperthermia during Desflurane - Succinylcholine Anesthesia for Neurosurgery: A case report. Baysal, Zeynep; Avci, Emel; Torun, Fuat; Cengiz, Mustafa; Çigdem, Ali; Togrul, Turhan; Nacar, Halil; Çakir, Ahmet // Internet Journal of Neurosurgery;2009, Vol. 5 Issue 2, p6 

    Desflurane has been known as a weak triggering anesthetic of malignant hyperthermia (MH). It may produce a delayed onset of symptoms. In addition the use of succinylcholine may aggravate occurrence of MH. The prolonged interval after exposure may occur more than 3 h after the induction of...

  • Malignant hyperthermia resolving with discontinuation of sevoflurane alone. Abolkhair, Abdullah; Seefelder, Christian // Saudi Journal of Anaesthesia;Apr2011, Vol. 5 Issue 2, p229 

    An otherwise healthy 13 year old developed hypercarbia and increased temperature during anesthesia with sevoflurane. Discontinuation of sevoflurane, surface cooling, and hyperventilation resulted in prompt resolution. However, hyperkalemia continued to raise the suspicion for malignant...

  • Fulminant-type malignant hyperthermia in Japan: cumulative analysis of 383 cases. Migita, Takako; Mukaida, Keiko; Kawamoto, Masashi; Kobayashi, Masako; Yuge, Osafumi // Journal of Anesthesia;2007, Vol. 21 Issue 2, p285 

    We investigated the transition of clinical signs of fulminant-type malignant hyperthermia (f-MH) by analyzing a database consisting of 383 cumulative cases of f-MH from 1961 to 2004. The cases were divided by time period into group 1 (1961–1984), group 2 (1985–1994), and group 3...

  • THE ICARUS EFFECT: THE INFLUENCE OF DILUENT WARMING ON DANTROLENE SODIUM MIXING TIME. Baker, Kevin R.; Landriscina, Donna; Kartchner, Heather; Mirkes, David M. // AANA Journal;Apr2007, Vol. 75 Issue 2, p101 

    Prompt administration of intravenous (IV) dantrolene sodium (DS) is the primary determinant of successful treatment of malignant hyperthermia (MH) syndrome. Because DS has a long reconstitution time for use in treating an MH crisis, we evaluated an alternative technique for hastening the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics